Medical providers trade favors with pharmaceutical companies, but do not deliver them to health insurance companies. This is still considered a cavalier offence in the industry, as a report from the financial control shows.
Doctors would have to pass on discounts that they receive when buying drugs to the premium payers. However, they often do not, as a new report reveals. Especially in the criticism stands the Federal Office for Health. It does not carry out the controls properly.